Koefisien rega marang bathi MBX Biosciences, Inc. (MBX)

MBX Biosciences Inc (MBX) ensures the reliable delivery of hormonal agents through distributed plants and strategic component reserves. The asset value tracked on the chart, currently at -19.40, is based on joint research with top universities in the field of endocrinology. Since the company is currently in the clinical trial stage, the ability to exercise pricing power will only emerge following FDA certification.

MBX MBX Corp: Koefisien rega marang bathi ing interval 20.03.2025 - 14.11.2026

Rincian metrik komprehensif lan analitis MBX Bio (MBX)

- rega saham lan prakiraan rega para ahli:

Bagan owah-owahan rega mbxbio.com|MBX - Bagan rega target

- rincian kapitalisasi pasar:

Biji pasar MBX Biosciences Inc|MBX - Nilai Perusahaan

- data ekuitas miturut neraca:

Nilai Aset Bersih saben Saham MBX Biosciences|MBX - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku mbxbio.com|MBX - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

- data bathi bisnis lan rasio investasi:

MBX - Bathi resik perusahaan|Prakiraan bathi perusahaan MBX Biosciences Inc|MBX - Rasio rega marang bathi|Prakiraan rega marang bathi MBX Biosciences, Inc.|MBX - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MBX Biosciences Inc|MBX - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan MBX Biosciences|MBX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan mbxbio.com|MBX - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep MBX Biosciences Inc

- rincian pendapatan lan dodolan emiten:

MBX - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan mbxbio.com|MBX - Multiplikator P/S|Rasio kapitalisasi marang dodolan sing dikarepake MBX Biosciences Inc

Analisis komprehensif perusahaan:MBX (mbxbio.com)

MBX Biosciences Inc (MBX) management's disciplined approach to capital during the development of endocrine drugs directly impacts net income dynamics. This metric compares the market value of the business with its actual financial result, measuring the cost of one dollar of profit. The indicator captures market expectations, allowing for an assessment of whether the asset is overbought or undervalued. Analysis of the calculated price-to-earnings multiple helps determine the company's margin of safety during periods of volatility.

Analisis perusahaan pesaing

ASND: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Madrigal Pharmaceuticals, Inc. (MDGL)|Koefisien rega marang bathi Corcept Therapeutics Inc. CORT|Pangali P/E RYTM (Rhythm Pharmaceuticals Inc)|Akero Corp (AKRO) - Kapitalisasi marang bathi|MTSR: Koefisien rega marang bathi|moonlaketx.com - Rasio rega pasar marang bathi resik|CRNX: Pangali P/E|NewAmsterdam Pharma Company (NAMS) - Pangali P/E|SLNO (Soleno) - Pangali P/E|Rasio rega marang bathi FOLD|Rasio rega marang bathi 89bio, Inc. (ETNB)|AGIO - Kapitalisasi marang bathi|Rasio rega marang bathi Structure Therapeutics Inc. GPCR|MiMedx Group Inc - Rasio rega marang bathi|Rezolute Corp - Pangali P/E|Periode bali modal bisnis Lexicon Corp LXRX|Altimmune, Inc. (ALT) - Rasio rega marang bathi|AARD - Periode bali modal bisnis|Rasio rega marang bathi Sagimet Biosciences Inc.|Koefisien rega marang bathi BioAge Labs (BIOA)|Rasio rega marang bathi Biomea (BMEA)|Koefisien rega marang bathi quincetx.com QNCX|Pangali P/E GUTS (Fractyl Health, Inc.)|vTv Therapeutics, Inc. - Rasio rega marang bathi|ATPC: Koefisien rega marang bathi|PLUR (Pluri Inc.) - Pangali rega marang bathi|SYBX (synlogictx.com) - Koefisien rega marang bathi|Lipocine Corporation - Nilai perusahaan marang bathi resik|MTNB (Matinas BioPharma Holdings, Inc.) - Pangali P/E|Rasio rega marang bathi SPRB|Pangali P/E GLTO|Periode bali modal bisnis Carmell Corp.|Rasio rega marang bathi Lumos Pharma Corp LUMO|Organovo Corp (ONVO) - Kapitalisasi marang bathi|RDUS - Rasio rega marang bathi